The Oral CYP17-Lyase (L) Inhibitor VT-464 in Patients With CRPC.

Journal of Clinical Oncology- United States

doi 10.1200/jco.2015.33.7_suppl.187

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society of Clinical Oncology (ASCO)

Related search

(464) Antioxidant Activity in Lingonberries (Vaccinium Vitis-Idaea L.)

Hortscience: A Publication of the American Society for Hortcultural Science
Horticulture
2005English

Oral Lichen Planus Developing After PD-1 Inhibitor Therapy in Two Patients With Malignant Melanoma

Journal of Clinical and Investigative Dermatology
2019English

A Novel Nonsense Mutation in Androgen Receptor Confers Resistance to CYP17 Inhibitor Treatment in Prostate Cancer

Oncotarget
Oncology
2016English

The Fungal Cyp-51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-Naïve and CYP17 Inhibitor-Naïve Patients: Follow-Up From the ARADES and ARAFOR Trials

European Urology Focus
Urology
2018English

Erratum To: Association of a CYP17 Polymorphism With Overall Survival in Caucasian Patients With Androgen-Independent Prostate Cancer

Urology
Urology
2016English

Activity of L-Phenylalanine Ammonia-Lyase in Winter Rape Leaves Treated With Cold.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
1993English

Oral Supplementation of L-Arginine in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)

Emirates Journal of Food and Agriculture
Applied MicrobiologyCrop ScienceFood ScienceAnimal ScienceZoologyBiotechnologyAgronomy
2003English

Oral or Intravenous Proton Pump Inhibitor in Patients With Peptic Ulcer Bleeding After Successful Endoscopic Epinephrine Injection

British Journal of Clinical Pharmacology
Pharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy